Upregulation of the Wnt/β-catenin pathway induced by transforming growth factor-β in hypertrophic scars and keloids

Acta Dermato-Venereologica

Volumn 86, Issue 4, 2006, Pages 300-307

  Sato, Madoka ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Fibrosis; p38 MAPK; Smad3; Wound healing

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; BETA CATENIN; COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADOLESCENT; ARTICLE; ASSAY; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; FIBROSIS; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; KELOID; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ADOLESCENT; BETA CATENIN; BLOTTING, WESTERN; CELL LINE; CHILD; CICATRIX, HYPERTROPHIC; COLLAGEN; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KELOID; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; SKIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; WNT PROTEINS; WOUND HEALING;

EID: 33746513742     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0101     Document Type: Article

References (32)

1. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-1851.
2. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6: 597-641.
3. Ignotz RA, Massagué J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix signals. J Biol Chem 1986; 261: 4337-4345.
4. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003; 425: 577-584.
5. Sato M, Shegogue D, Gore EA, Smith EA, McDermott PJ, Trojanowska M. Role of p38 MAPK in transforming growth factor-β stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J Invest Dermatol 2002; 118: 704-711.
6. Cheon SS, Cheah AY, Turley S, Nadesan P, Poon R, Clevers H, Alman BA. β-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc Natl Acad Sci USA 2002; 99: 6973-6978.
7. Cheon SS, Nadesan P, Poon R, Alman BA. Growth factors regulate β-catenin-mediated TCP-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp Cell Res 2004; 293: 267-274.
8. Riese J, Yu X, Munnerlyn A, Eresh S, Hsu SC, Grosschedl R, Bienz M. LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell 1997; 88: 777-787.
9. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer. Nature 2000; 403: 781-785.
10. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
11. Arakawa M, Hatamochi A, Mori Y, Mori K, Ueki H, Moriguchi T. Reduced collagenase gene expression in fibroblasts from hypertrophic scar tissue. Br J Dermatol 1996; 134: 863-868.
12. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-1787.
13. Sato M, Markiewicz M, Yamanaka M, Bielawska A, Mao C, Obeid LM, et al. Modulation of transforming growth factor-β (TGF-β) signaling by endogenous sphingolipid mediators. J Biol Chem 2003; 278: 9276-9282.
14. Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and α- and β-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 1996; 23: 1441-1447.
15. Sato M, Ishikawa O, Miyachi Y. An immunohistochemical study on transforming growth factor-β in the skin of systemic sclerosis patients with reference to the histopathologic stage. Eur J Dermatol 1996; 6: 482-485.
16. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type 1 collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad3. J Invest Dermatol 1999; 112: 49-57.
17. Labbé E, Letamendia A, Attisano L. Association of Smads with lymphoid enhancer binding factor1/T cell-specific factors mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci USA 2000; 97: 8358-8363.
18. Czuwara-Ladykowska J, Sementchenko VI, Watson DK, Trojanowska M. Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β. J Biol Chem 2002; 277: 20399-20408.
19. Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M, Longaker MT. Differential expression of transforming growth factor-β receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 2001; 108: 423-429.
20. Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF-2 regulation by the JNK signal transduction pathway. Science 1995; 267: 389-393.
21. Chilosi M, Poletti V, Zamò A, Lestani M, Montagna L, Piccoli P, et al. Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162: 1495-1502.
22. Hassanein AM, Glanz SM. β-catenin expression in benign and malignant pilomatrix neoplasms. Br J Dermatol 2004; 150: 511-516.
23. Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, et al. Transforming growth factor-β-mediated chonrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 2003; 278: 41227-41236.
24. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/β-catenin signaling. Adv Cancer Res 2000; 77: 1-24.
25. Rival C, Le Floch N, Sabbah M, Teyrol I, Redeuilh G, Bruyneel E, et al. Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. FASEB J 2003; 17: 1721-1723.
26. Verrecchia F, Mauviel A. Transforming growth factor-β signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002; 118: 211-215.
27. Piek E, Ju WJ, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, et al. Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 2001; 276: 19945-19953.
28. Roberts AB, Piek E, Böttinger EP, Ashcroft G, Mitchell JB, Flanders KC. Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? Chest 2001; 120: 43S-47S.
29. Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U. Studies of transforming growth factor β 1-3 and their receptors I and II in fibroblast of keliods and hypertrophic scars. Acta Derm Venereol 2005; 85: 216-220.
30. Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, Akiyama-Uchida Y, et al. Insulin-like growth factor-I enhances transforming growth factor-β-induced extracellular matrix protein production through the p38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol 2003; 120: 956-962.
31. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784.
32. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.